Clinical characteristics of patients undergoing robot-assisted laparoscopic radical prostatectomy and analysis of risk factors of positive surgical margins in a single center in a single center
FAN Xiaozheng1, QUAN Penghe1, ZHANG Longlong1, MA Shuaijun1, WANG Yanzhu1, QIN Weijun1, YUAN Jianlin1, YANG Xiaojian1
1Department of Urology, First Affiliated Hospital of Air Force Medical University, Xi'an 710032, China
Abstract:Objective: To analyze the clinical characteristics and risk factors of positive surgical margin of patients undergoing robot-assisted laparoscopic radical prostatectomy (RARP). Methods: The clinical data of patients with RARP in our department from January 2013 to December 2019 were collected and retrospectively analyzed. Logistic regression was used to analyze the risk factors of positive surgical margins in postoperative pathology. Results: The average age of 518 patients was (67.9 ± 7.3) years old, the preoperative median of TPSA was 19.09 μg/L, there were 183 asymptomatic patients (35.3%), 388 high-risk patients (74.90%) and 158 cases of postoperative positive surgical margin (30.5%). Logistic regression analysis showed that preoperative TPSA and clinical staging were the risk factors for positive surgical margin. Conclusion: In recent years, the age composition ratio of patients with RARP in our hospital has no significant change, and the proportion of asymptomatic patients has increased year by year. Preoperative TPSA and clinical staging were independent risk factors for positive surgical margin after radical prostatectomy.
范效铮, 权鹏鹤, 张龙龙, 马帅军, 王延柱, 秦卫军, 袁建林, 杨晓剑. 机器人辅助腹腔镜根治性前列腺切除术患者特征及切缘阳性分析[J]. 微创泌尿外科杂志, 2021, 10(2): 105-110.
FAN Xiaozheng, QUAN Penghe, ZHANG Longlong, MA Shuaijun, WANG Yanzhu, QIN Weijun, YUAN Jianlin, YANG Xiaojian. Clinical characteristics of patients undergoing robot-assisted laparoscopic radical prostatectomy and analysis of risk factors of positive surgical margins in a single center in a single center. JOURNAL OF MINIMALLY INVASIVE UROLOGY, 2021, 10(2): 105-110.
[1] 郑荣寿,孙可欣,张思维,等.2015年中国恶性肿瘤流行情况分析.中华肿瘤杂志,2019,41(1):19-28.
[2] BILL-AXELSON A, HOLMBERG L, GARMO H, et al.Radical prostatectomy or watchful waiting in prostate cancer-29-Year follow-up. N Engl J Med, 2018,379(24):2319-2329.
[3] LEOW JJ, CHANG SL, MEYER CP, et al.Robot-assisted Versus Open Radical Prostatectomy: A Contemporary Analysis of an All-payer Discharge Database. Eur Urol, 2016,70(5):837-845.
[4] 陈晶,梁朝朝,周骏,等.达芬奇机器人辅助腹腔镜泌尿外科手术500例回顾性分析.微创泌尿外科杂志,2018,7(2):77-82.
[5] 瞿旻,林恒之,王海峰,等.机器人辅助腹腔镜下根治性前列腺切除术治疗高危前列腺癌400例报告.中华泌尿外科杂志,2017,38(6):424-427.
[6] BRAVI CA, TIN A, VERTOSICK E, et al.The impact of experience on the risk of surgical margins and biochemical recurrence after Robot-Assisted radical prostatectomy: a learning curve study. J Urol, 2019,202(1):108-113.
[7] 那彦群,叶章群,孙颖浩,等.中国泌尿外科疾病诊断治疗指南手册(2014版).北京:人民卫生出版社,2013:65-67.
[8] 付振涛,郭晓雷,张思维,等.2015年中国前列腺癌发病与死亡分析.中华肿瘤杂志,2020,42(9):718-722.
[9] TOSOIAN JJ, GORIN MA, ROSS AE, et al.Oligometastatic prostate cancer: definitions, clinical outcomes, and treatment considerations. Nat Rev Urol, 2017,14(1):15-25.
[10] EPSTEIN JI, EGEVAD L, AMIN MB, et al.The 2014 international society of urological pathology (ISUP) consensus conference on gleason grading of prostatic carcinoma: definition of grading patterns and proposal for a new grading system. Am J Surg Pathol, 2016,40(2):244-252.
[11] BRAY F, FERLAY J, SOERJOMATARAM I, et al.Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2018,68(6):394-424.
[12] KLOTZ L, VESPRINI D, SETHUKAVALAN P, et al.Long-term follow-up of a large active surveillance cohort of patients with prostate cancer. J Clin Oncol, 2015,33(3):272-277.
[13] FLEMING CW, BROUGHMAN JR, TENDULKAR RD.Treatment options in oligometastatic disease in prostate cancer: thinking outside the box. Curr Treat Options Oncol, 2020,22(1):2.
[14] HEIDENREICH A, PFISTER D, PORRES D.Cytoreductive radical prostatectomy in patients with prostate cancer and low volume skeletal metastases: results of a feasibility and case-control study. J Urol, 2015,193(3):832-838.
[15] 叶定伟,李高翔,戴波,等.寡转移性前列腺癌的外科治疗进展.现代泌尿外科杂志,2017,22(4):249-252.
[16] FOSTER CC, WEICHSELBAUM RR, PITRODA SP.Oligometastatic prostate cancer: Reality or figment of imagination? Cancer, 2019,125(3):340-352.
[17] 琚官群,曹万里,汪存洲,等.达芬奇机器人在经尿道前列腺电切术后前列腺癌根治术的临床应用.微创泌尿外科杂志,2019,8(3):173-177.
[18] COUGHLIN GD, YAXLEY JW, CHAMBERS SK, et al.Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: 24-month outcomes from a randomised controlled study. Lancet Oncol, 2018,19(8):1051-1060.
[19] THOMPSON JE, EGGER S, BÖHM M, et al. Superior biochemical recurrence and long-term quality-of-life outcomes are achievable with robotic radical prostatectomy after a long learning Curve-Updated analysis of a prospective single-surgeon cohort of 2206 consecutive cases. Eur Urol, 2018,73(5):664-671.
[20] WANG L, WANG B, AI Q, et al.Long-term cancer control outcomes of robot-assisted radical prostatectomy for prostate cancer treatment: a meta-analysis. Int Urol Nephrol, 2017,49(6):995-1005.
[21] YOSSEPOWITCH O, BRIGANTI A, EASTHAM JA, et al.Positive surgical margins after radical prostatectomy: a systematic review and contemporary update. Eur Urol, 2014,65(2):303-313.
[22] WADHWA H, TERRIS MK, ARONSON WJ, et al.Long-term oncological outcomes of apical positive surgical margins at radical prostatectomy in the Shared Equal Access Regional Cancer Hospital cohort. Prostate Cancer Prostatic Dis, 2016,19(4):423-428.
[23] 张争,张克楠,洪保安,等.腹腔镜前列腺癌根治术后切缘阳性的相关影响因素分析.中国肿瘤临床,2019,46(6):299-302.
[24] CAO L, YANG Z, QI L, et al.Robot-assisted and laparoscopic vs open radical prostatectomy in clinically localized prostate cancer: perioperative, functional, and oncological outcomes: A Systematic review and meta-analysis. Medicine (Baltimore), 2019,98(22):e15770.
[25] 侯惠民,江炘,刘明,等.根治性前列腺切除术后切缘阳性的临床特征和影响因素分析.中华泌尿外科杂志,2018,39(10):740-744.
[26] 沈敏强,潘昊,汪朔,等.前列腺肉瘤26例回顾性分析.中华男科学杂志,2018,24(11):983-986.